Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses

Citation:

Antonia Wallrapp, Patrick R Burkett, Samantha J Riesenfeld, Se-Jin Kim, Elena Christian, Raja-Elie E Abdulnour, Pratiksha I Thakore, Alexandra Schnell, Conner Lambden, Rebecca H Herbst, Pavana Khan, Kazutake Tsujikawa, Ramnik J Xavier, Isaac M Chiu, Bruce D Levy, Aviv Regev, and Vijay K Kuchroo. 2019. “Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses.” Immunity, 51, 4, Pp. 709-723.e6. Copy at http://www.tinyurl.com/yy8alkqz
PDF4.96 MB

Abstract:

Neuroimmune interactions have emerged as critical modulators of allergic inflammation, and type 2 innate lymphoid cells (ILC2s) are an important cell type for mediating these interactions. Here, we show that ILC2s expressed both the neuropeptide calcitonin gene-related peptide (CGRP) and its receptor. CGRP potently inhibited alarmin-driven type 2 cytokine production and proliferation by lung ILC2s both in vitro and in vivo. CGRP induced marked changes in ILC2 expression programs in vivo and in vitro, attenuating alarmin-driven proliferative and effector responses. A distinct subset of ILCs scored highly for a CGRP-specific gene signature after in vivo alarmin stimulation, suggesting CGRP regulated this response. Finally, we observed increased ILC2 proliferation and type 2 cytokine production as well as exaggerated responses to alarmins in mice lacking the CGRP receptor. Together, these data indicate that endogenous CGRP is a critical negative regulator of ILC2 responses in vivo.
Last updated on 01/05/2021